Resistant hypertension remains a persistent challenge in primary care and specialist settings alike. Despite guideline-directed therapy with ACE inhibitors or ARBs, calcium channel blockers, and thiazide-like diuretics, many patients continue to have suboptimal blood...
Cardiovascular disease (CVD) continues to be the leading cause of death in the UK and globally, despite decades of public health advances and improvements in treatment. As clinicians, our ability to accurately assess risk is central to preventing serious...
The integration of artificial intelligence (AI) into primary care is no longer a futuristic concept—it’s here. With the recent NICE early value assessment (HTE24) guidance focusing on AI for assessing and triaging suspicious skin lesions, GPs are now at the forefront...
National Heart Week (April 29 – May 5) is a perfect time for healthcare professionals to encourage simple lifestyle changes that make a big impact on heart health. Whether you’re a GP, nurse, pharmacist, or allied health professional, your brief advice can empower...
Ryeqo for Endometriosis: A New Treatment, A Renewed Responsibility With NICE's recent approval of Ryeqo (relugolix, estradiol, norethisterone acetate) for use on the NHS, women of reproductive age now have a new treatment option for endometriosis. But this advancement...
In April 2025, the British Menopause Society (BMS) published new clinical guidance to support healthcare professionals managing women who are prescribed both incretin-based therapies and hormone replacement therapy (HRT). This comes at a crucial time, as GLP-1...
The 2024 NICE asthma guideline update marks a transformative step in asthma care, especially within primary care settings. With an emphasis on objective diagnosis, safer prescribing, and sustainability, this new guidance aims to improve outcomes and reduce variation...
The landscape of primary care in the UK is evolving, presenting numerous opportunities for pharmacists to play a pivotal role. However, misconceptions and uncertainties often deter many from exploring these roles. At CliniLink, we've engaged with pharmacists across...
Melatonin for Perimenopause and Menopause: Does It Improve Sleep Quality? Many women experience disrupted sleep during perimenopause and menopause, often due to hormonal changes that affect the body's natural circadian rhythm. As melatonin—the sleep hormone—declines...
Recent headlines reveal growing concerns among major pharmaceutical companies regarding the NHS rebate system. Companies such as AstraZeneca, GSK, and Pfizer have warned that high repayment rates,reported to reach up to 22.9% for newer medicines, are placing...
Mental Health and Wellbeing: Essential Strategies for a Healthier Mind Mental health is just as important as physical health, yet many people overlook it in their daily lives. With increasing stress levels, digital overload, and workplace pressures, taking proactive...
Hormone Replacement Therapy (HRT) is a widely used treatment for managing menopausal symptoms and protecting long-term health. For women with an intact uterus, combining oestrogen therapy with a progestogen is essential to prevent endometrial hyperplasia and reduce...
The Future of Pharmacy is Digital – Here’s What You Need to Know Artificial Intelligence (AI) is revolutionising the pharmaceutical industry, from drug discovery to patient care. Pharmacists and healthcare professionals are increasingly using AI-powered tools to...
Introduction: What I Learned About Insomnia and Cardiovascular Risk Recently, I attended a fascinating talk by Dr Yassir Javed, sponsored by Idorsia, where he discussed the link between insomnia and cardiovascular disease (CVD). As someone deeply interested in...
Sleep Hygiene Tips: Simple Ways to Sleep Better & Boost Wellbeing Improving sleep hygiene is crucial for maintaining mental and physical health. In today’s fast-paced world, many people struggle with getting enough quality sleep. Unfortunately, poor sleep can...
Inclisiran Clinical Trial: The Future of LDL-C Management in Primary Care High cholesterol is a significant contributor to cardiovascular diseases (CVD), affecting millions globally. While statins have long been the first-line therapy for reducing low-density...
Biggest Investment in UK General Practice in a Decade – What It Means for You For the first time in over a decade, NHS general practice is receiving a major financial boost, designed to tackle increasing patient demand, workforce shortages, and digital transformation....
GLP-1 Receptor Agonists and Hormonal Contraception: What You Need to Know The Faculty of Sexual and Reproductive Healthcare (FSRH) has issued guidance on how glucagon-like peptide-1 (GLP-1) receptor agonists interact with hormonal contraception. As the use of GLP-1...
Managing the increasing prevalence of diabetes in England is expected to be a significant clinical challenge in the 21st century. Currently, 3.6 million people in England are living with diabetes, and projections indicate this number could rise to 4.2 million by 2030,...